About
Vaccines
Areas of Focus
Categories
VaccineSoutheastern U.S.
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
254
By Phase
PHASE4: 2PHASE1/PHASE2: 1PHASE1: 1
By Status
COMPLETED: 3RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06828120Lead Sponsor
A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects
PHASE4Completed
45 participants
Started: Feb 20, 2025 · Completed: Sep 17, 2025
NCT06688292Lead Sponsor
The Safety and Effectiveness of Taneasy and Actein in COPD Patients
PHASE4Completed
42 participants
Started: Sep 20, 2024 · Completed: Dec 31, 2024
NCT05655182Lead Sponsor
A Study of BLB-201 RSV Vaccine in Infants and Children
PHASE1/PHASE2Recruiting
137 participants
Started: Mar 9, 2023 · Completed: Dec 23, 2026
NCT05281263Lead Sponsor
Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults
PHASE1Completed
30 participants
Started: Jul 20, 2022 · Completed: May 3, 2023
Locations (1)
Headquarters
Athens, GA, United States
Map
Loading map...